Technical Analysis for TLC - Taiwan Liposome Company, Ltd.

Grade Last Price % Change Price Change
grade F 5.25 -0.94% -0.05
TLC closed down 0.94 percent on Friday, June 21, 2019, on approximately normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical TLC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Reversal New Lows Setup Bearish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%

Older signals for TLC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.
Biopharmaceutical Drugs Inflammation Pharmacology Drug Delivery Arthritis Macular Edema Doxorubicin Peripheral Arterial Disease Amphotericin B Arbutus Biopharma Bupivacaine Liposome
Is TLC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 11.0
52 Week Low 5.02
Average Volume 2,654
200-Day Moving Average 0.0
50-Day Moving Average 5.6014
20-Day Moving Average 5.4762
10-Day Moving Average 5.4604
Average True Range 0.2382
ADX 19.03
+DI 27.9694
-DI 18.0744
Chandelier Exit (Long, 3 ATRs ) 5.0854
Chandelier Exit (Short, 3 ATRs ) 5.9646
Upper Bollinger Band 5.7199
Lower Bollinger Band 5.2325
Percent B (%b) 0.04
BandWidth 8.900332
MACD Line -0.0571
MACD Signal Line -0.0411
MACD Histogram -0.016
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.99
Resistance 3 (R3) 6.07 5.90 5.86
Resistance 2 (R2) 5.90 5.72 5.86 5.82
Resistance 1 (R1) 5.58 5.60 5.50 5.50 5.78
Pivot Point 5.41 5.41 5.37 5.37 5.41
Support 1 (S1) 5.09 5.23 5.01 5.01 4.72
Support 2 (S2) 4.92 5.11 4.88 4.68
Support 3 (S3) 4.60 4.92 4.64
Support 4 (S4) 4.52